Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155966

Options or other derivatives

  • President and CEO acquired 169,866 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2016-12-15 Grant or award : show line 1 in the form Stock option (right to buy) +145,600 145,600 D
2016-12-15 Grant or award : show line 2 in the form Restricted stock units +24,266 24,266 D
Loading xslF345X03/doc4.xml…